RaySearch Laboratories AB (publ)
STO:RAY B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
RaySearch Laboratories AB (publ)
Other Current Liabilities
RaySearch Laboratories AB (publ)
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
RaySearch Laboratories AB (publ)
STO:RAY B
|
Other Current Liabilities
kr457m
|
CAGR 3-Years
182%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
ContextVision AB
OSE:CONTX
|
Other Current Liabilities
kr20.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
|
M
|
Mentice AB
STO:MNTC
|
Other Current Liabilities
kr3.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
O
|
Ortivus AB
STO:ORTI B
|
Other Current Liabilities
kr8.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Sectra AB
STO:SECT B
|
Other Current Liabilities
kr308.8m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-2%
|
|
|
i
|
iZafe Group AB
STO:IZAFE B
|
Other Current Liabilities
kr7m
|
CAGR 3-Years
57%
|
CAGR 5-Years
44%
|
CAGR 10-Years
56%
|
|
RaySearch Laboratories AB (publ)
Glance View
RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. The company is headquartered in Stockholm, Stockholm. The company markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
See Also
What is RaySearch Laboratories AB (publ)'s Other Current Liabilities?
Other Current Liabilities
457m
SEK
Based on the financial report for Dec 31, 2025, RaySearch Laboratories AB (publ)'s Other Current Liabilities amounts to 457m SEK.
What is RaySearch Laboratories AB (publ)'s Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
8%
Over the last year, the Other Current Liabilities growth was -14%. The average annual Other Current Liabilities growth rates for RaySearch Laboratories AB (publ) have been 182% over the past three years , 8% over the past five years .
